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OBJECTIVE
Small vessel disease, as measured by white matter 
hyperintensity (WMH) in the brain, is known to be associated 
with increased stroke risk and cognitive impairment [1,2]. 
Vascular stiffness is also considered an independent risk factor 
for stroke[3,4].  This study explored the relationship between 
WMH on computerised tomography (CT), vascular stiffness, 
and white coat hypertension/effect (WCH/E) in patients with 
recent transient ischaemic attack (TIA) or lacunar stroke (LS).
DESIGN AND METHOD
Ninety-six patients recruited for the ASIST trial (Arterial 
Stiffness in Lacunar Stroke and TIA) underwent measurement of 
clinic blood pressure (BP) and ambulatory BP monitoring 
(APBM) within two weeks of TIA or LS. Twenty-three patients 
had normotension (clinic BP <140/90mmHg and day-time 
ABPM <135/85mmHg) and 25 patients had WCH/E (clinic BP 
>/=140/90mmHg and day-time ABPM <135/85mmHg). Arterial 
stiffness was measured using carotid-femoral pulse wave 
velocity (PWV) (Complior®, ALAM Medical) and carotid-
ankle vascular index (CAVI) (VaSera VS-1500N®, Fukuda 
Denshi). CT images were rated for WMH using the four-point 
Fazekas visual rating scale [5,6], where 0=no WMH, 1=mild 
WMH (small, separate white matter lesions), 2=moderate WMH 
(confluent joined up lesions around the ventricles), and 3=severe 
WMH (white matter lesions extending from ventricle into the 
cortex). The rater was trained on 30 images by a consultant 
neuroradiologist. Patients were grouped into no-mild WMH 
(scores 0-1) or moderate-severe (scores 2-3) groups. The 
relationship between BP, vascular stiffness and WMH was 
explored with t-tests, chi-square and logistic regression 
accounting for known cardiovascular risk factors.
Figure 1. CT images of Fazekas 1-3. A – Fazekas 1, B – Fazekas 
2, C – Fazekas 3 [7].
RESULTS
Forty-four percent of patients with WCH/E had moderate-severe 
WMH compared to 17% of normotensives (p=0.047). Arterial 
stiffness was higher in the WCH/E group compared to 
normotensives (CAVI 10.3 + 1.1 vs 9.2 + 1.5 p = 0.007; PWV 
12.2 + 3.2 vs 9.5 + 2.3 p= 0.003). The regression model with 
WMH as the dependent factor, and WCH/E and cardiovascular 
risk factors as independent factors showed WCH/E and either 
CAVI or PWV to be the only independent significant factor 
contributing to WMH (CAVI:p=0.038, PWV:p=0.043).
CONCLUSIONS
Patients with WCH/E were more likely to have moderate-severe 
WMH on CT than normotensives. WCH/E group had increased 
WMH, likely modulated by vascular stiffness, independent of 
other cardiovascular risk factors.
This study suggests that WCH/E is associated with increased 
WMH in the brain and may benefit from treatment.
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Table 1: Results Normotension
(N=23)
WCH/E 
(N=25)
Statistical 
Sig.
Female n(%) 8 (35%) 7 (28%) p=0.613
Age (years) 69.7+/-11.8 76.5+/-8.7 p=0.026
Ever Smoker n(%) 12 (52%) 18 (72%) p=0.156
Anti-hypertensive use 
n(%)
15 (65%) 20 (80%) p=0.250
Hyperlipidaemia n(%) 18 (78%) 15 (60%) p=0.458
Diabetes n(%) 4 (17%) 7 (28%) p=0.173
CAVI 9.2+/-1.5 10.3+/-1.1 p=0.007
PWV 9.5+/-2.3 12.2+/-3.1 p=0.003
No-Mild WMH n(%) 19 (83%) 14 (66%)
p=0.047
Moderate-Severe 
WMH n(%)
4 (17%) 11(44%)
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